Skip to content

SCHEDULE 13GAccepted Nov 18, 4:07 PM ET

Keros Therapeutics, Inc. SCHEDULE 13G

ExodusPoint Capital Management, LP

Accepted (ET)

4:07 PM

Nov 18, 2025

Filed

Nov 18, 2025

Documents

2

Size

18.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.